How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?-Reference-Cited by-同舟云学术

How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?

Published:2013-01-14 Issue:1 Volume:15 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Norton Nadine,Perez Edith A

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr3335.pdf

Reference15 articles.

1. Vaz-Luis I, Ottesen RA, Hughes ME, Marcom PK, Moy B, Rugo HS, Theriault RL, Wilson J, Niland JC, Weeks JC, Lin NU: Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study. Breast Cancer Res. 2012, 14: R129-10.1186/bcr3324.

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005, 365: 1687-1717.

3. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R: Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011, 378: 771-784.

4. Genentech Inc. Herceptin ® (trastuzumab). US Prescribing information [online]. 2008, San Francisco, CA: Genentech Inc, [ http://www.gene.com/gene/products/information/pdf/herceptin-prescribing.pdf ]

5. Perez EA, Suman VJ, Davidson NE, Martino S, Kaufman PA, Lingle WL, Flynn PJ, Ingle JN, Visscher D, Jenkins RB: HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial. J Clin Oncol. 2006, 24: 3032-3038. 10.1200/JCO.2005.03.4744.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA Regulation of Breast Cancer Stemness;International Journal of Molecular Sciences;2021-04-04

2. Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients;Breast Cancer Research and Treatment;2013-07-31